Andrey Loboda's Biography

Andrey Loboda, Associate Director, Merck Laboratories

Andrey Loboda, Ph.D., is Data Analysis Head in Informatics and Analysis Department of Early at Merck Co., Inc. Collaborating with Merck Clinical and Basic Research, Dr. Loboda is responsible for integrative analysis of genetic and genomics data aimed at discovery, validation and development of biomarkers for use in the clinical development of novel cancer therapeutics. Dr. Loboda graduated with honors from Moscow Institute of Physics and Technology and earned his Ph.D. from the University of Pennsylvania, Philadelphia under Dr. Clay Armstrong. Dr. Loboda pursued his post-doctoral training in computational biology at Wistar Institute under the direction of Dr. Louise Show.

Integrated Analysis of Genetic and Genomic Data from Tumor Cohorts Reveals Molecular Architecture and Suggests Selection Criteria for Treatment with Targeted Therapies

Thursday, 19 April 2012 at 09:00

Add to Calendar ▼2012-04-19 09:00:002012-04-19 10:00:00Europe/LondonIntegrated Analysis of Genetic and Genomic Data from Tumor Cohorts Reveals Molecular Architecture and Suggests Selection Criteria for Treatment with Targeted TherapiesSELECTBIOenquiries@selectbiosciences.com

This talk will discuss how genetic and genomic profiling can help address unmet medical needs in Oncology. It will provide examples of integrated analysis of gene expression signature profiles with mutation and copy number variation data across cell line panels and cohorts of tumor samples. By linking the molecular subtypes with drug response in cell lines and clinical outcomes in tumor cohorts it will propose patient selection strategies.

Add to Calendar ▼2012-04-19 00:00:002012-04-20 00:00:00Europe/LondonGenomic BiomarkersSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors